Jasaeng Korean Medicine Hospital Directly Refutes 'Health Insurance Privilege Allegations'... Announces Legal Action

Jasaeng Korean Medicine Hospital issued a lengthy statement on the 21st directly refuting the allegations of preferential treatment in health insurance that have spread to the National Assembly.

Recently, during a full meeting of the National Assembly's Health and Welfare Committee, suspicions of preferential treatment in health insurance surrounding Jasaeng Korean Medicine Hospital were raised. These suspicions were based on allegations presented by the independent media outlet Newstapa on the 8th. Newstapa claimed that ▲Jasaeng Korean Medicine Hospital violated Ministry of Health and Welfare standards by receiving health insurance benefits for several months before being caught ▲there was evidence that Shin Junsik, Honorary Director of Jasaeng Korean Medicine Hospital, was involved in the Ministry of Health and Welfare’s process of including Harpagophytum root, the raw material of 'Cheongpajeon,' which is suspected of preferential health insurance coverage, into the health insurance benefit items ▲the Ministry of Health and Welfare assigned a research project that had failed preliminary feasibility approval years ago to a research center operated by Jasaeng Korean Medicine Hospital, among other allegations.

In response, Jasaeng Korean Medicine Hospital systematically refuted these allegations. Regarding claims of improper receipt of health insurance benefits for herbal prescriptions not covered by health insurance, the hospital explained, "We have never been caught or sanctioned by the Ministry of Health and Welfare or the Health Insurance Review & Assessment Service, and we strictly comply with related guidelines when claiming health insurance benefit costs." Regarding 'Cheongpajeon,' they stated it is not the name of an herbal product but a prescription composition (herbal combination), and that they follow Ministry of Health and Welfare guidelines by applying the same prescription composition principles to health insurance herbal decoctions. They also explained that Harpagophytum root is distributed as an herbal medicine with product approval by 15 companies besides Jasaeng Korean Medicine Hospital. They denied other allegations as being factually incorrect.

Jasaeng Korean Medicine Hospital particularly addressed the preferential treatment suspicions related to Lee Wonmo, the Presidential Office’s Public Service Discipline Secretary, being the son-in-law of Shin Junsik, Honorary Director of Jasaeng Korean Medicine Hospital. They stated, "Even the reports indicate that no evidence of preferential treatment involving Secretary Lee has been revealed," and added, "It is inappropriate to conclusively accuse the Presidential Office of providing preferential treatment based on previous suspicions." They further said, "Many of the allegations raised this time were implemented by previous administrations, so simply attributing them to collusion with the current government is logically unsound." Jasaeng Korean Medicine Hospital declared that they will hold the reporting media legally accountable.

This content was produced with the assistance of AI translation services.